Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).
Clinical trial NCT05534789 · TERMINATED
Trial details
- NCT number
- NCT05534789
- Sponsor
- Pfizer
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-15
- Primary completion
- 2023-12-13
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.